[Causes and treatment of anaphylaxis in a Mexican third-level pediatric hospital].

Q3 Medicine
Lina Castaño-Jaramillo, Carla Toledo-Salinas, David Mendoza
{"title":"[Causes and treatment of anaphylaxis in a Mexican third-level pediatric hospital].","authors":"Lina Castaño-Jaramillo,&nbsp;Carla Toledo-Salinas,&nbsp;David Mendoza","doi":"10.29262/ram.v68i3.904","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To clinically characterize the events of anaphylaxis in a third-level pediatric hospital.</p><p><strong>Methods: </strong>1148 clinical records were reviewed. Eventually, the information of 35 events of anaphylaxis in 20 patients was analyzed; three of them had multiple episodes of anaphylaxis.</p><p><strong>Results: </strong>The median age for the anaphylactic episodes was 11 years (Interquartile range 10 years, Q1 = 5, Q3 = 15), predominantly in adolescents between the ages of 12 and 17 years, and there was a slight predominance in women. The most frequent clinical manifestations were cutaneous (86%), followed by respiratory (83%), cardiovascular (74%), and gastrointestinal (46%) alterations. Cardiac arrest was documented in three episodes; however, no anaphylaxis-related deaths were reported. The main triggers for anaphylaxis were food (34%), medications (29%), allergen-specific immunotherapy (14%), and latex (11%). In patients with perioperative anaphylaxis, the clinical behavior was severe. Epinephrine was administered in 27 out of the 35 events (77%), but only in 11 cases it was the first-line treatment. Systemic corticosteroids were the most frequently used treatment, followed by epinephrine and antihistamines.</p><p><strong>Conclusions: </strong>The use of epinephrine, which is the mainstay of the treatment, is suboptimal; with a preferred use of second-line medications like corticosteroids. Clear protocols for the diagnosis and treatment of anaphylaxis, as well as continuous education of health personnel, are necessary.</p>","PeriodicalId":21175,"journal":{"name":"Revista alergia Mexico","volume":"68 3","pages":"160-164"},"PeriodicalIF":0.0000,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista alergia Mexico","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29262/ram.v68i3.904","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 1

Abstract

Objective: To clinically characterize the events of anaphylaxis in a third-level pediatric hospital.

Methods: 1148 clinical records were reviewed. Eventually, the information of 35 events of anaphylaxis in 20 patients was analyzed; three of them had multiple episodes of anaphylaxis.

Results: The median age for the anaphylactic episodes was 11 years (Interquartile range 10 years, Q1 = 5, Q3 = 15), predominantly in adolescents between the ages of 12 and 17 years, and there was a slight predominance in women. The most frequent clinical manifestations were cutaneous (86%), followed by respiratory (83%), cardiovascular (74%), and gastrointestinal (46%) alterations. Cardiac arrest was documented in three episodes; however, no anaphylaxis-related deaths were reported. The main triggers for anaphylaxis were food (34%), medications (29%), allergen-specific immunotherapy (14%), and latex (11%). In patients with perioperative anaphylaxis, the clinical behavior was severe. Epinephrine was administered in 27 out of the 35 events (77%), but only in 11 cases it was the first-line treatment. Systemic corticosteroids were the most frequently used treatment, followed by epinephrine and antihistamines.

Conclusions: The use of epinephrine, which is the mainstay of the treatment, is suboptimal; with a preferred use of second-line medications like corticosteroids. Clear protocols for the diagnosis and treatment of anaphylaxis, as well as continuous education of health personnel, are necessary.

[墨西哥一家三级儿科医院过敏反应的原因和治疗]。
目的:了解某三级儿科医院过敏反应事件的临床特点。方法:对1148例临床资料进行回顾性分析。最后对20例患者的35例过敏反应事件信息进行分析;其中三人有多次过敏反应。结果:过敏发作的中位年龄为11岁(四分位数范围为10岁,Q1 = 5, Q3 = 15),主要发生在12 - 17岁的青少年中,女性略有优势。最常见的临床表现是皮肤(86%),其次是呼吸(83%)、心血管(74%)和胃肠道(46%)的改变。有3次心脏骤停记录;然而,没有过敏相关的死亡报告。过敏反应的主要触发因素是食物(34%)、药物(29%)、过敏原特异性免疫疗法(14%)和乳胶(11%)。围手术期过敏反应患者临床行为严重。在35例病例中,有27例(77%)使用了肾上腺素,但只有11例是一线治疗。全身性皮质类固醇是最常用的治疗方法,其次是肾上腺素和抗组胺药。结论:以肾上腺素为主的治疗效果不理想;首选使用皮质类固醇等二线药物。有必要制定明确的诊断和治疗过敏反应的方案,并对卫生人员进行持续教育。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Revista alergia Mexico
Revista alergia Mexico Medicine-Immunology and Allergy
CiteScore
0.70
自引率
0.00%
发文量
9
审稿时长
16 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书